Scope of the Study
The excimer lasers ar the type of gas lasers which aims a high-intensity ultraviolet B (UVB) light at a specific wavelength of -- 308 nanometers -- directly at the psoriasis plaques, it is a disease on skin, in this, the laser does not touches the skin and thus reduces the risk of UV radiation on skin. Its applications are not limited to dermatology but is also used in vision treatment commonly called ophthalmology, for microfabrication photolithography). The excimer laser are also used in scientific research laboratories to pump the dye lasers.
The market study is being classified by Type (Argon Laser, Fluoride Laser and Others), by Application (Ophthalmology, Dermatology, Photolithography, Scientific Research and Others) and major geographies with country level break-up.
Abbott Laboratories Inc. (United States), Bausch & Lomb Incorporated (United States), Alcon Corporation (Switzerland), Carl Zeiss Meditec AG (Germany), SCHWIND Eye-Tech-Solutions (Germany), Coherent, Inc. (United States), STRATA Skin Sciences Inc. (United States), Nidek Co. Ltd. (Japan), AMS Technologies AG (Germany) and Laser 2000 GmbH (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Optosystems Ltd. (Russia) and Andrec Corporation (United States).
AdvanceMarketAnalytics has segmented the market of Global Excimer Laser market by Type, Application and Region.
On the basis of geography, the market of Excimer Laser has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of Eye Related Diseases Across the Emerging Countries
- Rising Need for Treatment of Psoriasis
- The Rising Use of Excimer Laser in Opthalmology
- Continuous Advancements in Laser Technology
- Problems with Impact of Laser Radiation on Environment
- Stringent Regulatory Standards might be the Hindrance
- Growth in Skin Sciences will Boost the Excimer Laser Market
- Potential Growth Opportunities for Excimer Laser for Research Application
- Health-related Concerns Associated with Excimer Laser
- A large number of Players with Low Performing Excimer Laser
On 23rd January 2020, Strata Skin Sciences announced the FDA clearance of its Xtrac Momentum excimer laser system. This laser system delivers the highly targeted therapeutic beam of UVB light and is cleared to treat psoriasis. Along with vitiligo, eczema, atopic dermatitis, and leukoderma – skin diseases that impact over 35 million patients in the United States alone. The new clearance is the first full platform clearance (since the XTRAC Velocity platform was cleared in 2010). Named Momentum, the cleared platform creates the foundation for the upcoming technological developments in the Company’s worldwide install base.
Key Target AudienceExcimer Laser Manufacturers, Excimer Laser International Traders, Excimer Laser Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Upstream and Downstream Buyers, Industry Associations and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase